Director, Microvascular Biology Laboratory

Henri Parson

     Dr. Henri Parson joined the EVMS Strelitz Diabetes Center in January of 2001. During her initial two years at the Center, she was extensively involved in the coordination of a clinical research study involving physical activity, in situ nitric oxide measurements and neurovascular dysfunction. Subsequently, she was awarded a two-year American Diabetes Association (ADA) fellowship to continue performing research on the mechanistic defects involved with diabetic neuropathy. She has presented her work at ADA scientific meetings and has been published in several peer-reviewed journals. Dr. Parson was also awarded the honor of being a Health Disparities Scholar by the National Institutes of Health, National Institute on Minority Health and Health Disparities. Dr. Parson was promoted to Director of the Microvascular Biology Lab at the Strelitz Diabetes Center in 2007. During this time, she has assisted in obtaining over 10 grants to further her mission to better understand the neurovascular dysfunction that occurs in diabetic neuropathy, and to delineate the cultural and socioeconomic disparities involved in the high rate of diabetic ulcerations and amputations in minority populations. In conjunction with these goals, Dr. Parson leads the development of advanced, non-invasive, innovative devices for detecting diabetic neuropathy prior to its clinical manifestation.  

Selected Publications

  • Parson HK, Bridges JN, Willie C, Vinik AI: Ethnic Sensitivity is Important when Assessing the Health Care Needs of the African-American Population, Diabetes, Vol. 53, Suppl. 2, A552, 2004

  • Colberg SR, Parson HK, Nunnold T, Holton DR, Swain DP, Vinik AI: Change in cutaneous perfusion following 10 weeks of aerobic training in Type 2 diabetes, Journal of Diabetes and Its Complications, Vol. 19, 276-283, 2005

  • Colberg SR, Parson HK, Nunnold T, Herriott MT, Vinik AI: Effect of an 8-week Resistance Training Program on Cutaneous Perfusion in Type 2 Diabetes, Microvascular Research, Vol. 71(2), 121-127, March, 2006

  • Vinik AI, Ullal J, Parson HK, Casellini CM: Diabetic Neuropathies:  Clinical Manifestations and current treatment options, Nature Clinical Practice Endocrinology and Metabolism, Vol. 2(4), 2006

  • Vinik AI, Parson HK, Ullal J: The Role of PPARs in the Microvascular Dysfunction in Diabetes. Vascular Pharmacology, 45(1), 54-64, 2006 

  • Parson HK, Nguyen VT, Boyd, AL, Vinik A. CHEPS Detects Neuropathic Changes Earlier than Traditional Clinical Measures.  Vol. 58, Diabetes, Suppl. June 2009

  • Parson HK, Bundy MA, Dublin CB, Boyd AL, Paulson JF, Vinik AI.  Pleiotropic effects of rosuvastatin on microvascular function in type 2 diabetes.  Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy 3:19-26, 2010

  • Lieb DC, Parson HK, Mamikunian G, Vinik AI. Cardiac Autonomic Imbalance in Newly Diagnosed and Established Diabetes Is Associated with Markers of Adipose Tissue Inflammation Experimental Diabetes Research,2012:1-8, 2011

  • Parson HK, Harati H, Cooper D, Vinik AI. The Role of Prostaglandin D2 and the Autonomic Nervous System on Niacin Induced Flushing. Journal of Diabetes, 2012

  • Parson HK, Nguyen VT, Orciga MA, Boyd AL, Casellini CM, Vinik AI. Contact Heat-Evoked Potential Stimulation for the Evaluation of Small Nerve Fiber Function. Diabetes Technology and Therapeutics, 2013.